Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
211.50    -0.50 (-0.24%)
Bid:
210.00
Ask:
213.00
Spread: 3.00 (1.429%)
Market Cap: £144.31m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Directorate Change

1 Jul 2024 07:00

RNS Number : 5464U
Helios Underwriting Plc
01 July 2024
 

Helios Underwriting plc

("Helios" or the "Company")

1st July 2024

Appointment of Non-Executive Director

Helios Underwriting ('Helios' or the 'Company'), the only publicly traded investment company offering instant access to a diverse portfolio at Lloyd's of London, the world's largest insurance market, is pleased to announce the appointment to the Board of John Chambers as an Independent Non-Executive Director. John's appointment took effect after the Company's Annual General Meeting on 28th June 2024.

 

John previously worked at AEGIS London, where he was Director of Underwriting, and helped build the business from a fledgling syndicate into one of the largest and most profitable in the London Market. He brings considerable experience across all aspects of running a regulated insurer, from business planning through underwriting management to risk management, as well as financial and regulatory reporting.

 

Michael Wade, Executive Chairman of Helios, commented: "I am pleased to announce that John will be joining our Board as an Independent Non-Executive Director. He brings with him considerable experience of running a highly successful Lloyd's business. I'm looking forward to working closely with him as we seek to capitalise on excellent market conditions and maintain our status as the pre-eminent provider of private capital to the Lloyd's market."

 

John Chambers, added: "The Lloyd's market is highly regulated, financially robust, and uniquely positioned. Market conditions have never been better, with increased underwriting discipline and sustainable price increases expected to last for years. I'm excited to add my knowledge of the Lloyd's market to Helios' already highly experienced Board, as we help drive forward the strategy and actively manage a balanced portfolio of Lloyd's syndicate participations."

 

 

AIM Rule 17

The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies:

 

John Edmond Chambers, aged 59, owns or has an interest in 560,000 ordinary shares in the Company. John Chambers' current and previous directorships are as follows:

 

Current Partnerships / Directorships

Previous Partnerships / Directorships (last 5 years)

Dora Holdings Jersey Limited

Fairburn Bistromathics Limited

Fairburn Capital Limited

Fairburn Continuation Limited

TT Club Mutual Insurance Ltd

Through Transport Mutual Insurance Association Limited

 

AEGIS Managing Agency Limited

St. Thomas More Catholic Primary School

 

Save as disclosed above, there are no further disclosures to be made in accordance with Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

For further information, please contact:

Helios Underwriting plc

Michael Wade - Chairman

Arthur Manners - Chief Financial Officer +44 (0)203 965 6441

Deutsche Numis (Nomad and Broker)

 Giles Rolls / Charles Farquhar

+44 (0)20 7260 1000

 

FTI Consulting

 Ed Berry / Nathan Hambrook-Skinner

+44 (0)7703 330 199 / +44 (0)7977 817 092

 About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £507m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGGNKMRGDZG
Date   Source Headline
1st Sep 20237:00 amRNSTotal Voting Rights
31st Aug 202311:05 amRNSTransaction in Own Shares
30th Aug 20234:05 pmRNSTransaction in Own Shares
30th Aug 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
29th Aug 202312:30 pmRNSTransaction in Own Shares
25th Aug 20232:12 pmRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in own shares
23rd Aug 202311:44 amRNSShare Repurchase Programme
21st Aug 20234:23 pmRNSNotification of Major Holdings
21st Aug 202311:40 amRNSDirector's Shareholding
18th Aug 20238:22 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20234:30 pmRNSShare Repurchase Programme
2nd Aug 20237:00 amRNSTotal Voting Rights
25th Jul 20237:00 amRNSAcquisition
14th Jul 20237:00 amRNSDirector Dealing
14th Jul 20237:00 amRNSAcquisition of Limited Liability Vehicle
13th Jul 20237:00 amRNSIssue of Equity
4th Jul 20237:00 amRNSResults of Scrip Dividend Election
29th Jun 20233:46 pmRNSDirectorship Change
29th Jun 202311:27 amRNSResults of Annual General Meeting
29th Jun 20237:00 amRNSNotification of Major Holdings
16th Jun 20237:00 amRNSScrip Dividend Reference Price
7th Jun 20233:53 pmRNSDirector’s Shareholding
5th Jun 20233:39 pmRNSFinal Dividend Timetable
5th Jun 20237:00 amRNSDirector’s/PCA Shareholdings
1st Jun 20237:00 amRNSGrant of LTIP Award
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
31st May 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
26th May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSChange of Adviser
11th May 20237:00 amRNSDirectors' Disclosure
11th Apr 20237:00 amRNSDirector's/PCAs' Shareholding
5th Apr 20237:00 amRNSGrant of LTIP Award and Director Dealing
5th Apr 20237:00 amRNSDirector/PCA Shareholdings
4th Apr 20237:00 amRNSDirectorate Change
4th Apr 20237:00 amRNSQuarterly Syndicate Mid Point Forecasts
10th Jan 20237:00 amRNS2023 Helios Retained Capacity Update
29th Dec 20223:38 pmRNSAcquisitions of LLVs, Issue of Equity and TVR
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 202212:06 pmRNSHolding(s) in Company
19th Dec 20229:07 amRNSGrant of LTIP Awards and Directors' Dealings
14th Dec 202212:47 pmRNSHolding(s) in Company
13th Dec 202211:29 amRNSResult of GM, TVR and Directors' Participation
12th Dec 20227:00 amRNSResult of Open Offer
24th Nov 202212:54 pmRNSReplacement - Result of Placing and Subscription
24th Nov 20227:00 amRNSResult of Placing and Subscription
23rd Nov 20224:45 pmRNSFundraising to raise up to approximately £13.5m
29th Sep 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.